PDF herunterladen
CC BY-NC-ND 4.0 · Int Arch Otorhinolaryngol 2017; 21(04): 399-407
DOI: 10.1055/s-0036-1597825
Systematic Review
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Head and Neck Lymphomas in HIV Patients: a Clinical Perspective

Natsuki Oishi
1   ENT Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain
2   ENT Department, Universitat de Valencia Facultat de Medicina i Odontologia, Valencia, Comunitat Valenciana, Spain
,
José Vicente Bagán
3   Department of Stomatology, Consorci Hospital General Universitari de Valencia, Valencia, Comunitat Valenciana, Spain
,
Karla Javier
4   Department of Haematology, Consorci Hospital General Universitari de Valencia, Valencia, Comunitat Valenciana, Spain
,
Enrique Zapater
1   ENT Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain
› Institutsangaben
Weitere Informationen

Publikationsverlauf

16. Juli 2016

31. Oktober 2016

Publikationsdatum:
01. Februar 2017 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Introduction Because of the many HIV-related malignancies, the diagnosis and treatment of lymphoma in patients infected with human immunodeficiency virus are challenging.

Objective Here, we review current knowledge of the pathogenesis, epidemiology, symptomatology, diagnosis, and treatment of head and neck lymphomas in HIV patients from a clinical perspective.

Data Synthesis Although Hodgkin's lymphoma is not an AIDS-defining neoplasm, its prevalence is ten times higher in HIV patients than in the general population. NHL is the second most common malignancy in HIV patients, after Kaposi's sarcoma. In this group of patients, NHL is characterized by rapid progression, frequent extranodal involvement, and a poor outcome. HIV-related salivary gland disease is a benign condition that shares some features with lymphomas and is considered in their differential diagnosis.

Conclusion The otolaryngologist may be the first clinician to diagnose head and neck lymphomas. The increasing survival of HIV patients implies clinical and epidemiological changes in the behavior of this disease. Early diagnosis is important to improve the prognosis and avoid the propagation of HIV infection.

Keywords

HIV - lymphoma - head and neck neoplasms
 

  • References

  • 1 Boring CC, Squires TS, Tong T. Cancer statistics, 1993. CA Cancer J Clin 1993; 43 (01) 7-26
    CrossrefPubMedSuche in Google Scholar
  • 2 zur Hausen H. Viruses in human cancers. Science 1991; 254 (5035) 1167-1173
    CrossrefPubMedSuche in Google Scholar
  • 3 Ioachim HL. Immunopathogenesis of human immunodeficiency virus infection. Cancer Res 1990; 50 (17, Suppl) 5612S-5617S
    PubMedSuche in Google Scholar
  • 4 Centers for Disease Control. Revisions of the CDC surveillance case definition for adquired immunodeficiency syndrome. MMWR 1987; 36: 1-15
    Suche in Google Scholar
  • 5 Carbone A, Tirelli U, Gloghini A, Volpe R, Boiocchi M. Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol 1993; 11 (09) 1674-1681
    CrossrefPubMedSuche in Google Scholar
  • 6 Cioc AM, Allen C, Kalmar JR, Suster S, Baiocchi R, Nuovo GJ. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 2004; 28 (01) 41-46
    CrossrefPubMedSuche in Google Scholar
  • 7 Jaffe ES, Harris NL, Stein H, Isaacson PG. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008; 112 (12) 4384-4399
    CrossrefPubMedSuche in Google Scholar
  • 8 Carbone A. AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment. Hum Pathol 2002; 33 (04) 392-404
    CrossrefPubMedSuche in Google Scholar
  • 9 Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 2000; 27 (04) 390-401
    PubMedSuche in Google Scholar
  • 10 Tirelli U, Errante D, Dolcetti R. , et al. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 1995; 13 (07) 1758-1767
    CrossrefPubMedSuche in Google Scholar
  • 11 Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin lymphoma. Lancet 1991; 337 (8745): 805-809
    CrossrefPubMedSuche in Google Scholar
  • 12 Tirelli U, Spina M, Gaidano G, Vaccher E, Franceschi S, Carbone A. Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy. AIDS 2000; 14 (12) 1675-1688
    CrossrefPubMedSuche in Google Scholar
  • 13 Bower M, Stebbing J. AIDS-associated malignancies. Cancer Chemother Biol Response Modif 2005; 22: 687-706
    PubMedSuche in Google Scholar
  • 14 Dolcetti R, Gloghini A, Caruso A, Carbone A. A lymphomagenic role for HIV beyond immune suppression?. Blood 2016; 127 (11) 1403-1409
    CrossrefPubMedSuche in Google Scholar
  • 15 Corti M, Villafañe M, Bistmans A, Narbaitz M, Gilardi L. Primary extranodal non-hodgkin lymphoma of the head and neck in patients with acquired immunodeficiency syndrome: a clinicopathologic study of 24 patients in a single hospital of infectious diseases in Argentina. Int Arch Otorhinolaryngol 2014; 18 (03) 260-265
    Thieme ConnectPubMedSuche in Google Scholar
  • 16 Purgina B, Pantanowitz L, Seethala RR. A Review of Carcinomas Arising in the Head and Neck Region in HIV-Positive Patients. Pathol Res Int 2011; 2011: 469150
    Suche in Google Scholar
  • 17 Zapater E, Bagan JV, Campos A, Armengot M, Abril V, Basterra J. Non-Hodgkin's lymphoma of the head and neck in association with HIV infection. Ann Otolaryngol Chir Cervicofac 1996; 113 (02) 69-72
    PubMedSuche in Google Scholar
  • 18 Finn DG. Lymphoma of the head and neck and acquired immunodeficiency syndrome: clinical investigation and immunohistological study. Laryngoscope 1995; 105 (4 Pt 2, Suppl 68) 1-18
    Suche in Google Scholar
  • 19 Wood C, Harrington Jr W. AIDS and associated malignancies. Cell Res 2005; 15 (11-12) 947-952
    CrossrefSuche in Google Scholar
  • 20 Zapater E, Bagán JV, Carbonell F, Basterra J. Malignant lymphoma of the head and neck. Oral Dis 2010; 16 (02) 119-128
    CrossrefPubMedSuche in Google Scholar
  • 21 Weisenburger DD. Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic. Ann Oncol 1994; 5 (Suppl. 01) 19-24
    PubMedSuche in Google Scholar
  • 22 Laskar S, Mohindra P, Gupta S, Shet T, Muckaden MA. Non-Hodgkin lymphoma of the Waldeyer's ring: clinicopathologic and therapeutic issues. Leuk Lymphoma 2008; 49 (12) 2263-2271
    CrossrefPubMedSuche in Google Scholar
  • 23 Nathu RM, Mendenhall NP, Almasri NM, Lynch JW. Non-Hodgkin's lymphoma of the head and neck: a 30-year experience at the University of Florida. Head Neck 1999; 21 (03) 247-254
    CrossrefPubMedSuche in Google Scholar
  • 24 Oluwasanmi AF, Wood SJ, Baldwin DL, Sipaul F. Malignancy in asymmetrical but otherwise normal palatine tonsils. Ear Nose Throat J 2006; 85 (10) 661-663
    CrossrefPubMedSuche in Google Scholar
  • 25 Kemp S, Gallagher G, Kabani S, Noonan V, O'Hara C. Oral non-Hodgkin's lymphoma: review of the literature and World Health Organization classification with reference to 40 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105 (02) 194-201
    CrossrefPubMedSuche in Google Scholar
  • 26 Bagan JV, Carbonell F, Gómez MJ. , et al. Extra-nodal B-cell non-Hodgkin's lymphomas of the head and neck: a study of 68 cases. Am J Otolaryngol 2015; 36 (01) 57-62
    CrossrefPubMedSuche in Google Scholar
  • 27 Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992; 80 (01) 8-20
    CrossrefPubMedSuche in Google Scholar
  • 28 Ferrazzo KL, Mesquita RA, Aburad AT, Nunes FD, de Sousa SO. EBV detection in HIV-related oral plasmablastic lymphoma. Oral Dis 2007; 13 (06) 564-569
    CrossrefPubMedSuche in Google Scholar
  • 29 Simo R, Hartley C, Malik T, Wilson GE, Taylor PH, Mandal BK. Primary non-Hodgkin's lymphoma of the larynx in an AIDS patient. J Laryngol Otol 1998; 112 (01) 77-80
    CrossrefPubMedSuche in Google Scholar
  • 30 Weber AL, Rahemtullah A, Ferry JA. Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation. Neuroimaging Clin N Am 2003; 13 (03) 371-392
    CrossrefPubMedSuche in Google Scholar
  • 31 Aiken AH, Glastonbury C. Imaging Hodgkin and non-Hodgkin lymphoma in the head and neck. Radiol Clin North Am 2008; 46 (02) 363-378 , ix–x
    CrossrefPubMedSuche in Google Scholar
  • 32 Swedlow SH, Campo E, Harris NL. , et al. 2008. . Eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. WHO⁄International Agency for Research on Cancer; Lyon:
    Suche in Google Scholar
  • 33 Boué F, Gabarre J, Gisselbrecht C. , et al. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. J Clin Oncol 2006; 24 (25) 4123-4128
    CrossrefPubMedSuche in Google Scholar
  • 34 Ribera JM, Oriol A, Morgades M. , et al; PETHEMA, GELTAMO, GELCAB and GESIDA Groups. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial. Br J Haematol 2008; 140 (04) 411-419
    CrossrefPubMedSuche in Google Scholar
  • 35 Little RF, Pittaluga S, Grant N. , et al. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 2003; 101 (12) 4653-4659
    CrossrefPubMedSuche in Google Scholar
  • 36 Barta SK, Lee JY, Kaplan LD, Noy A, Sparano JA. Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma. Cancer 2012; 118 (16) 3977-3983
    CrossrefPubMedSuche in Google Scholar
  • 37 Sparano JA, Lee S, Chen MG. , et al. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494). J Clin Oncol 2004; 22 (08) 1491-1500
    CrossrefPubMedSuche in Google Scholar
  • 38 Spina M, Jaeger U, Sparano JA. , et al. Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials. Blood 2005; 105 (05) 1891-1897
    CrossrefPubMedSuche in Google Scholar
  • 39 Spina M, Simonelli C, Vaccher E. , et al. Long-term follow-up of rituximab and infusional cyclophosphamide, doxorubicin, and etoposide (CDE) in combination with HAART in HIV related Non-Hodgkin Lymphomas (NHL) [abstract]. Blood 2008; 1467: 112 available at: http://www.bloodjournal.org/content/112/11/1467
    Suche in Google Scholar
  • 40 Cortes J, Thomas D, Rios A. , et al. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer 2002; 94 (05) 1492-1499
    CrossrefPubMedSuche in Google Scholar
  • 41 Thomas DA, Faderl S, O'Brien S. , et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer 2006; 106 (07) 1569-1580
    CrossrefPubMedSuche in Google Scholar
  • 42 Thomas DA, Kantarjian HM, Cortes J. , et al. Long-term outcome after hyper-CVAD and rituximab chemoimmunotherapy for Burkitt (BL) or Burkitt-like (BLL) leukemia/lymphoma and mature B-cell acute lymphocytic luekemia (ALL) [abstract]. Blood 2008; 1929: 112 available at: http://www.bloodjournal.org/content/112/11/1929
    Suche in Google Scholar
  • 43 Wang ES, Straus DJ, Teruya-Feldstein J. , et al. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer 2003; 98 (06) 1196-1205
    CrossrefPubMedSuche in Google Scholar
  • 44 Barnes JA, Lacasce AS, Feng Y. , et al. Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis. Ann Oncol 2011; 22 (08) 1859-1864
    CrossrefPubMedSuche in Google Scholar
  • 45 Noy A, Kaplan L, Lee J. , et al. Modified dose intensive R-CODOX-M/IVAC for HIV-associated Burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression. Infect Agent Cancer 2012; 7 (Suppl. 01) 14
    CrossrefPubMedSuche in Google Scholar
  • 46 Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood 2015; 125 (15) 2323-2330
    CrossrefPubMedSuche in Google Scholar
  • 47 Dunleavy K, Pittaluga S, Czuczman MS. , et al. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood 2009; 113 (24) 6069-6076
    CrossrefPubMedSuche in Google Scholar
  • 48 Okada S, Goto H, Yotsumoto M. Current status of treatment for primary effusion lymphoma. Intractable Rare Dis Res 2014; 3 (03) 65-74
    CrossrefPubMedSuche in Google Scholar
  • 49 Hocqueloux L, Agbalika F, Oksenhendler E, Molina JM. Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy. AIDS 2001; 15 (02) 280-282
    CrossrefPubMedSuche in Google Scholar
  • 50 Luppi M, Trovato R, Barozzi P. , et al. Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir. Leukemia 2005; 19 (03) 473-476
    CrossrefSuche in Google Scholar
  • 51 Halfdanarson TR, Markovic SN, Kalokhe U, Luppi M. A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy. Ann Oncol 2006; 17 (12) 1849-1850
    CrossrefPubMedSuche in Google Scholar
  • 52 Hentrich M, Berger M, Wyen C. , et al. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study. J Clin Oncol 2012; 30 (33) 4117-4123
    CrossrefPubMedSuche in Google Scholar
  • 53 Kim SJ, Kim WS. Treatment of localized extranodal NK/T cell lymphoma, nasal type. Int J Hematol 2010; 92 (05) 690-696
    CrossrefPubMedSuche in Google Scholar
  • 54 Wang ZY, Li YX, Wang WH. , et al. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents. Blood 2009; 114 (23) 4771-4776
    CrossrefPubMedSuche in Google Scholar
  • 55 Kim WS, Song SY, Ahn YC. , et al. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?. Ann Oncol 2001; 12 (03) 349-352
    CrossrefPubMedSuche in Google Scholar
  • 56 Kim SJ, Kim K, Kim BS. , et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study. J Clin Oncol 2009; 27 (35) 6027-6032
    CrossrefPubMedSuche in Google Scholar
  • 57 Yamaguchi M, Tobinai K, Oguchi M. , et al. Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211. J Clin Oncol 2012; 30 (32) 4044-4046
    PubMedSuche in Google Scholar
  • 58 Jiang M, Zhang H, Jiang Y. , et al. Phase 2 trial of “sandwich” L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma. Cancer 2012; 118 (13) 3294-3301
    CrossrefPubMedSuche in Google Scholar
  • 59 Levine AM, Sadeghi S, Espina B, Tulpule A, Nathwani B. Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection. Cancer 2002; 94 (05) 1500-1506
    CrossrefPubMedSuche in Google Scholar
  • 60 Hermans J, Krol AD, van Groningen K. , et al. International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades. Blood 1995; 86 (04) 1460-1463
    Suche in Google Scholar
  • 61 Ziepert M, Hasenclever D, Kuhnt E. , et al. Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. J Clin Oncol 2010; 28 (14) 2373-2380
    CrossrefPubMedSuche in Google Scholar
  • 62 Corey JP, Seligman I. Otolaryngology problems in the immune compromised patient--an evolving natural history. Otolaryngol Head Neck Surg 1991; 104 (02) 196-203
    CrossrefPubMedSuche in Google Scholar
  • 63 Leess FR, Kessler DJ, Mickel RA. Non-Hodgkin's lymphoma of the head and neck in patients with AIDS. Arch Otolaryngol Head Neck Surg 1987; 113 (10) 1104-1106
    CrossrefPubMedSuche in Google Scholar
  • 64 Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med 1997; 102 (5B): 9-15
    PubMedSuche in Google Scholar
  • 65 Ippolito G, Puro V, De Carli G. The risk of occupational human immunodeficiency virus infection in health care workers. Italian Multicenter Study. The Italian Study Group on Occupational Risk of HIV infection. Arch Intern Med 1993; 153 (12) 1451-1458
    CrossrefPubMedSuche in Google Scholar
  • 66 Haines T, Stringer B, Herring J, Thoma A, Harris KA. Surgeons' and residents' double-gloving practices at 2 teaching hospitals in Ontario. Can J Surg 2011; 54 (02) 95-100
    CrossrefPubMedSuche in Google Scholar
  • 67 Mischke C, Verbeek JH, Saarto A, Lavoie MC, Pahwa M, Ijaz S. Gloves, extra gloves or special types of gloves for preventing percutaneous exposure injuries in healthcare personnel. Cochrane Database Syst Rev 2014; 3 (03) CD009573
    Suche in Google Scholar
  • 68 Parantainen A, Verbeek JH, Lavoie MC, Pahwa M. Blunt versus sharp suture needles for preventing percutaneous exposure incidents in surgical staff. Cochrane Database Syst Rev 2011; (11) CD009170
    Suche in Google Scholar
  • 69 Kuhar DT, Henderson DK, Struble KA. , et al. US Public Health Service Working Group. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol 2013; 34 (09) 875-892
    CrossrefSuche in Google Scholar
  • 70 Ihrler S, Zietz C, Riederer A, Diebold J, Löhrs U. HIV-related parotid lymphoepithelial cysts. Immunohistochemistry and 3-D reconstruction of surgical and autopsy material with special reference to formal pathogenesis. Virchows Arch 1996; 429 (2-3) 139-147
    PubMedSuche in Google Scholar
  • 71 Greaves WO, Wang SA. Selected topics on lymphoid lesions in the head and neck regions. Head Neck Pathol 2011; 5 (01) 41-50
    CrossrefPubMedSuche in Google Scholar
  • 72 Fishleder A, Tubbs R, Hesse B, Levine H. Uniform detection of immunoglobulin-gene rearrangement in benign lymphoepithelial lesions. N Engl J Med 1987; 316 (18) 1118-1121
    CrossrefPubMedSuche in Google Scholar
  • 73 Barta SK, Xue X, Wang D. , et al. A new prognostic score for AIDS-related lymphomas in the rituximab-era. Haematologica 2014; 99 (11) 1731-1737
    CrossrefPubMedSuche in Google Scholar